Previous Article | Next Article 
Infection and Immunity, March 1999, p. 1207-1212, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Pseudomonas aeruginosa Secretory
Product Pyocyanin Inactivates
1 Protease Inhibitor:
Implications for the Pathogenesis of Cystic Fibrosis Lung
Disease
Bradley E.
Britigan,1,2,*
Michelle
A.
Railsback,2 and
Charles D.
Cox3
Medical Service, VA Medical Center, Iowa
City, Iowa 52246,1 and Departments of
Internal Medicine2 and
Microbiology,3 The University of Iowa
College of Medicine, Iowa City, Iowa 52242
Received 10 September 1998/Returned for modification 19 October
1998/Accepted 18 December 1998
 |
ABSTRACT |
1 Protease inhibitor (
1PI) modulates
serine protease activity in the lung. Reactive oxygen species
inactivate
1PI, and this process has been
implicated in the pathogenesis of a variety of forms of lung injury.
An imbalance of protease-antiprotease activity is also
detected in the airways of patients with cystic fibrosis-associated lung disease who are infected with
Pseudomonas aeruginosa. P. aeruginosa secretes
pyocyanin, which, through its ability to redox cycle, induces
cells to generate reactive oxygen species. We tested the hypothesis
that redox cycling of pyocyanin could lead to inactivation of
1PI. When
1PI was exposed to NADH and
pyocyanin, a combination that results in superoxide
production,
1PI lost its ability to form an inhibitory
complex with both porcine pancreatic elastase (PPE) and trypsin.
Similarly, addition of pyocyanin to cultures of human airway
epithelial cells to which
1PI was also added resulted in
a loss of the ability of
1PI to form a complex with
PPE or trypsin. Neither superoxide dismutase, catalase, nor
dimethylthiourea nor depletion of the media of O2 to
prevent formation of reactive oxygen species blocked pyocyanin-mediated inactivation of
1PI. These data raise the possibility
that a direct interaction between reduced pyocyanin and
1PI is involved in the process. Consistent with this
possibility, pretreatment of
1PI with the reducing agent
-mercaptoethanol also inhibited binding of trypsin to
1PI. These data suggest that pyocyanin could contribute
to lung injury in the P. aeruginosa-infected airway of cystic fibrosis patients by decreasing the ability of
1PI to control the local activity of serine proteases.
 |
INTRODUCTION |
Tight regulation of local protease
activity is critical to the maintenance of the physiologic function of
the lung and other tissue sites (15, 40, 48). Serine
proteases such as neutrophil elastase are among the proteases found
within the human airway (15, 16, 20, 38, 40). Serine
protease activity must be tightly regulated in order to protect local
tissue from protease-mediated injury. This is accomplished in vivo
through the presence of a group of proteins which specifically inhibit
serine protease activity (32, 40, 48). Among the key
antiproteases in the airway is
1-protease inhibitor
(
1PI) (32, 40, 48).
1PI is a 51-kDa protein member of the serpin class of serine protease inhibitors (32, 40, 48).
1PI forms a nearly irreversible
enzymatically inactive complex with various serine proteases, including
human neutrophil elastase (HNE), porcine pancreatic elastase (PPE), and
trypsin (29, 40, 48). The active site of
1PI
provides a putative cleavage site for the target enzymes, and it is the methionine 358 within that location which is key for both the protease
specificity and inhibitory activity of
1PI.
Modifications of this methionine markedly decrease the inhibitory
activity of
1PI (29, 40, 48).
A number of laboratories have shown that exposure of
1PI
to various oxidant sources, including activated phagocytes (6, 14,
28, 34, 39, 50) and cigarette smoke (17, 41), results
in rapid inactivation of the protein due to oxidation of methionine 358 (31). Since the hereditary decrease in
1PI activity leads to early-onset emphysema (10), it has been
postulated that oxidant-mediated inactivation of
1PI,
resulting in decreased local regulation of serine protease activity, is
an important contributor to the pathophysiology of cigarette-associated
chronic obstructive lung disease (6, 30).
An imbalance of protease-antiprotease activity is also detected in the
airways of patients with cystic fibrosis-associated lung disease
(5, 16, 18, 19, 35). Most of this elevated protease activity
is due to an increase in HNE activity (23, 43, 45). Studies
indicate that the untoward protease imbalance is a result of both
elevated amounts of HNE and the presence of functionally inactive
1PI (1, 2, 5, 35, 38, 44). The reason for the
presence of inactive
1PI is unclear.
The onset of progressive lung disease in cystic fibrosis usually
coincides with the development of persistent colonization and infection
of the airway with Pseudomonas aeruginosa. P. aeruginosa secretes a number of potentially cytotoxic factors,
including the phenazine derivative pyocyanin (21, 24, 25,
51). Under aerobic conditions, exposure of pyocyanin to NADH or
other cell-derived reducing equivalents, leads to redox cycling of the
compound with resultant formation of superoxide
(O2·
) and hydrogen peroxide
(H2O2) (4, 11, 22, 24, 25). Given
the ability of pyocyanin to induce oxidant production, we hypothesized
that this P. aeruginosa-derived product could
contribute to the pathogenesis of the protease-mediated component of
cystic fibrosis lung disease by serving as an additional source of
oxidant-mediated inactivation of
1PI. The in vitro work
reported herein supports the ability of redox cycling of pyocyanin to
inactivate
1PI. However, the mechanism may not directly
involve oxidant production.
 |
MATERIALS AND METHODS |
Reagents.
NADH, CuZn superoxide dismutase (SOD), trypsin,
porcine pancreatic elastase (PPE), H2O2,
methionine, histidine, catalase, and dimethylthiourea (DMTU) were
obtained from Sigma Chemical Co., St. Louis, Mo.
1PI was
purchased from Calbiochem, La Jolla, Calif. The PPE preparations
contain chymotrypsin-trypsin (25 to 100 U of trypsin activity/mg of
protein) as an impurity. 5,5 Dimethyl-N-pyrroline 1-oxide
(DMPO) was purchased from the Oklahoma Medical Research Foundation,
Oklahoma City, Okla.
Ability of
1PI to form a complex with serine
proteases.
1PI (10 µg/ml) in H2O was
incubated with either PPE (50 to 200 µg/ml) or trypsin (50 to 200 µg/ml) for 15 to 30 min at 37°C. Aliquots of the reaction mixture
were then added to Laemmli solubilizing buffer and subjected to
standard sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). The results were similar regardless of whether or not the
gels were run under reducing conditions. The
1PI-protease complex is well known to remain associated
under these conditions (7, 31, 46). Detection of an
1PI-protease complex was assessed by either (i) staining
the gel with silver and determining the presence or absence of a new
band with an apparent molecular weight consistent with a complex of
1PI and the protease; or (ii) transfer of the
SDS-PAGE-separated sample to nitrocellulose. The nitrocellulose was
then blocked with 4% bovine serum albumin-Tris-buffered saline for
1 h and then incubated overnight with a 1:100 dilution of rabbit
anti-human
1PI (Sigma). The blots were then washed three
times, and immunoreactive protein was determined with antirabbit
immunoglobulin G linked to alkaline phosphatase. The
1PI-protease complex was manifested as the presence of
an
1PI immunoreactive band with an apparent molecular
weight higher than that of an
1PI standard.
1PI activity.
1PI activity was
measured in terms of
1PI's ability to inhibit
PPE-mediated cleavage of
succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide (Sigma) according to the spectrophotometric assay of Travis and Johnson
(47).
Cell culture of human lung epithelial cells.
The A549 human
lung carcinoma cell line which resembles type II alveolar epithelial
cells was maintained in continuous culture with Dulbecco's
modification of Eagle's medium (DMEM) obtained through the University
of Iowa Cancer Center, Iowa City. The culture medium was routinely
supplemented with 10% heat-inactivated fetal bovine serum, 1%
penicillin-streptomycin, and 1% glutamine. HBE cells were cultivated
in a similar manner, except that the primary culture medium was 50%
DMEM and 50% HAM (hepatocyte medium F12; University of Iowa Cancer
Center). For each set of experiments, cells from the stock culture were
seeded (2.5 × 104 to 5 × 104
cells/well) into 24- or 48-well plates. Cells were maintained at 37°C
in 5% CO2 until they were at least 80% confluent (usually 72 h), at which time they were utilized in the desired experiments.
Purification of pyocyanin.
Pyocyanin was extracted from
culture supernatant of P. aeruginosa PAO1 (ATCC 15692;
American Type Culture Collection, Rockville, Md.) by serial chloroform
extractions followed by sequential extractions with acid and neutral
water as previously detailed (9). After the completion of
five separation sequences, the pyocyanin was crystallized and dried
under vacuum. It was resuspended in water and stored at 4°C until used.
Effect of pyocyanin redox cycling on
1PI-protease
complex formation.
Experiments were performed in which
1PI (or, in some cases, the target protease) was exposed
to either NADH- or cell-mediated redox cycling of pyocyanin.
1PI (10 µg/ml) was added either to a solution of NADH
(6 mM) in H2O or to an A549 or HBE cell monolayer in
Hanks' balanced salt solution after which the desired concentration of
pyocyanin was added. The system was then incubated for 30 min at
37°C. At this point, trypsin or PPE (200 µg/ml) was added for an
additional 15 min (37°C). The solutions were assessed for the formation of
1PI-protease complex as described above.
EPR and spin trapping.
For spin trapping experiments, the
spin trap DMPO (100 mM) and diethylenetriaminepentaacetic acid (DTPA
[0.1 mM]) were included in the reaction mixture of interest. After
the desired time of incubation, the reaction mixture was transferred to
an electron paramagnetic resonance (EPR) quartz flat cell and placed
into the cavity of the EPR spectrometer (ES 300; Brüker,
Karlsrühe, Germany). EPR spectra were then obtained at 25°C
with the following parameters: 4.00 × 109 gain,
335.544-s sweep time, 100-kHz modulation frequency, 0.501-G modulation
amplitude, 80-G sweep width, 9.76-GHz frequency, and 20 mW of power.
For detection of the pyocyanin radical, 40 µM pyocyanin was added to
a 44 µM solution of NADH and 0.1 mM DTPA, which had been sparged with
N2 for 20 min. The pyocyanin and NADH were then allowed to
react at 25°C in the continuous presence of N2 and
subjected to EPR spectroscopy with a Varian E-104A EPR spectrometer
(Varian Associates, Inc., Palo Alto, Calif.) with a 1-s time constant,
8-min scan time, 2.5 × 104 gain, 100-kHz
modulation frequency, and 20 mW of power.
 |
RESULTS |
Pyocyanin-NADH blocks
1PI-protease complex
formation.
Several laboratories, including our own, have shown
that addition of NADH to pyocyanin leads to the reduction of pyocyanin to the pyocyanin radical (4, 11, 22, 24-26). Under aerobic conditions, the pyocyanin radical will transfer an electron to O2, leading to the formation of
O2·
(4, 11, 22,
24-26). Consistent with these earlier data (4, 11, 22,
24-26), when NADH and pyocyanin were incubated under conditions
in which O2 was previously depleted from the system by
N2 bubbling, an EPR spectrum indicative of the pyocyanin radical was detected (data not shown). When the same reaction was
performed under aerobic conditions, the pyocyanin radical was no longer
seen, but O2.
production was
readily detected by DMPO spin trapping (data not shown).
Given the susceptibility of
1PI to inactivation by
oxidant species (6, 17, 41, 52), the ability of
NADH-mediated redox cycling of pyocyanin to decrease
1PI
activity was assessed. As shown in Fig. 1
and 2, the presence of NADH and pyocyanin
decreased the ability of
1PI to form a stable complex
with either trypsin or PPE. Concentrations of pyocyanin required to
completely prevent detectable complex formation varied from experiment
to experiment, ranging from 25 to 125 µM. In the PPE experiments, a
major protease-
1PI complex (top) and a somewhat fainter
protease-
1PI complex (bottom) were routinely observed.
The lower bands are likely due to the presence of chymotrypsin and/or
trypsin, which routinely contaminate commercial PPE preparations and
also form a complex with
1PI. Neither NADH nor pyocyanin
alone prevented formation of the
1PI-protease complex
(data not shown), indicating that reduction of pyocyanin was required.
These results were similar, regardless of whether the
1PI-protease complex was detected by silver staining or
immunoblot analysis.

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblot with antisera to 1PI in which
gel samples were comprised of 10 µg of 1PI alone (lane
1); 1PI which had been incubated with trypsin for 30 min
at 37°C (lane 2); or 1PI and 200 µg of trypsin along
with 6 mM NADH and pyocyanin at a concentration of 12.5 µM (lane
3), 50 µM (lane 4), and 100 µM (lane 5). The arrow designates the
location of the complex formed by 1PI and trypsin. The
results are representative of 10 experiments.
|
|

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoblot with antisera to 1PI. The gel
sample in lane 1 consisted of 1PI which had been
incubated for 30 min at 37°C with 200 µg of PPE. Lane 2 shows
results obtained under the same conditions as lane 1, except that 6 mM
NADH and 100 µM pyocyanin were added prior to the addition of PPE to
the reaction mixture. The results are representative of five separate
experiments.
|
|
An additional feature frequently noted when the NADH-pyocyanin
combination was present was a decrease in the apparent quantity of
1PI detectable on the gel and evidence of proteolytic
degradation products of
1PI (Fig. 1 and 2). The fact
that these were detected by anti-
1PI immunoblotting
indicates they indeed reflect degradation of
1PI.
Lower-molecular-weight bands reactive with anti-
1PI were
not observed with NADH-pyocyanin-treated
1PI unless an
active protease was also added to the reaction mixture (data not shown [n = 3]). These data are consistent with the
hypothesis that NADH-pyocyanin exposure leads to a modification of
1PI, such that the antiprotease is converted to a
legitimate substrate for PPE or trypsin.
Since the incubation conditions described above resulted in exposure of
trypsin and PPE to NADH-pyocyanin as well as
1PI, experiments were performed so that we could be certain that the effect
of NADH-pyocyanin was on
1PI and not the protease.
1PI-protease complex formation was compared under
conditions in which
1PI or the protease was first
exposed to NADH-pyocyanin for 30 min, after which, the protease or
1PI was then added to the system, respectively, and
1PI-protease complex formation was assessed (Fig.
3). When
1PI was first
incubated with NADH-pyocyanin and then PPE or trypsin was added, no
1PI-protease complex was generated (Fig. 3). In
contrast, when trypsin or PPE was the component incubated initially
with NADH-pyocyanin, after which
1PI was added, the same
magnitude of
1PI-protease complex was observed as in the non-NADH-pyocyanin-treated control (Fig. 3). These results indicate that the effect of NADH-pyocyanin is on
1PI rather than
the protease.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoblot with antisera to 1PI in which
gel samples were comprised of 10 µg of 1PI plus 200 µg of trypsin which had been incubated for 30 min at 37°C. Lanes 1 to 3 show the results obtained when 1PI was previously
exposed to 6 mM NADH and 100 µM pyocyanin alone (lane 1), or with SOD
(300 U/ml; lane 2) or catalase (5,000 U/ml; lane 3) added, for 20 min
prior to the addition of trypsin to the reaction mixture. Samples in
lanes 4 to 6 were obtained under the same conditions as those of lanes
1 to 3, except that the trypsin rather than the 1PI was
previously exposed to 6 mM NADH and 100 µM pyocyanin alone (lane 4),
or with SOD (300 U/ml; lane 5) or catalase (5,000 U/ml; lane 6) added,
for 30 min prior to its interaction with 1PI. The
results are representative of three experiments.
|
|
Biochemical evidence of NADH-pyocyanin inactivation of
1PI.
As confirmation that exposure to
NADH-pyocyanin leads to loss of
1PI functional
activity, the ability of NADH-pyocyanin-treated
1PI to inhibit PPE enzymatic activity was
assessed.
1PI exposed to NADH-pyocyanin
exhibited an impaired ability to inhibit PPE cleavage of
succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide. In the absence of
1PI, cleavage of
succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide by PPE yielded a change in A410 of 0.132 ± 0.012 U/min (mean ± standard error [SE]; n = 10). Addition of
1PI decreased this to
0.040 ± 0.005 U/min (mean ± SE; n = 10).
When
1PI was first exposed to NADH-pyocyanin for 10 min,
its ability to inhibit PPE activity was significantly decreased
(P < 0.001 by analysis of variance) because
A410 was 0.076 ± 0.009 U/min (mean ± SE; n = 10). NADH-pyocyanin had no effect on PPE
activity as assessed in this assay (data not shown).
Epithelial cell-mediated redox cycling of pyocyanin inactivates
1PI.
In vivo redox cycling of pyocyanin in the
P. aeruginosa-infected airway would likely occur via
epithelial cell-mediated reduction of the compound rather via its
interaction with extracellular NADH or NADPH. We have previously shown
that incubation of monolayers of A549 (3, 12, 37) or HBE
cells (12) with pyocyanin results in the formation of
O2·
, as detected by spin trapping.
Since initial reduction of pyocyanin would likely occur
intracellularly, it was unclear whether cell-mediated redox cycling of
pyocyanin could inactivate extracellular
1PI. In order
to assess this, A549 (or HBE) monolayers were incubated with
1PI (10 µg/ml) ± pyocyanin (10 to 200 µM) for 30 min. PPE or trypsin was then added, and after 15 min of additional
incubation, formation of
1PI-protease complex in the
extracellular milieu was assessed by immunoblot analysis. As shown in
Fig. 4 and
5, the presence of pyocyanin resulted in
a marked decrease in the subsequent ability of
1PI to
form a complex with either trypsin or PPE. This was dependent on the
concentration of pyocyanin present. As with NADH-pyocyanin,
supernatants from pyocyanin-treated, but not control, epithelial cells
often exhibited evidence of
1PI proteolysis (Fig. 4).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 4.
Immunoblot with antisera to 1PI in which
gel samples were comprised of supernatants removed from monolayers of
HBE cells 30 min following the addition of 1PI (lane 1),
1PI plus 50 µM pyocyanin (lane 2), and
1PI plus 200 µM pyocyanin (lane 3), which were then
mixed with trypsin for 30 min at 37°C. Each sample was subjected to
SDS-PAGE and immunoblot analysis as described in Materials and Methods.
The results are representative of three experiments.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 5.
Immunoblot with antisera to 1PI in which
gel samples were comprised of supernatants removed from monolayers of
A549 cells 30 min following the addition of 1PI (lane 2)
or 1PI plus 100 µM pyocyanin (lane 3), which were then
mixed with trypsin for 30 min at 37°C. The samples were then
subjected to SDS-PAGE and immunoblot analysis as described in Materials
and Methods. Lane 1 contains only 1PI, which was not
incubated with trypsin and is included as a reference. The results are
representative of three experiments.
|
|
Role of reactive oxygen intermediates in pyocyanin-associated
inactivation of
1PI.
The ability of neutrophils to
inactivate
1PI is linked to oxidation of the protein by
reactive oxygen species, particularly those arising from the reaction
of H2O2 and myeloperoxidase (MPO) (6, 14,
34, 52). Accordingly, we postulated that oxidant species
resulting from pyocyanin-induced
O2·
formation were responsible for
NADH-pyocyanin-mediated inhibition of
1PI activity. In
order to test this, we determined if the presence of SOD, catalase, or
the H2O2-hydroxyl radical scavenger DMTU
blocked NADH-pyocyanin-mediated inactivation of
1PI.
Surprisingly, none of these agents alone nor the combination of SOD and
catalase exhibited any ability to block the effect of NADH-pyocyanin
(Fig. 3). SOD and catalase are reasonably large proteins, raising the possibility that they were unable to adequately reach the site of
1PI which required protection. However, we found that
methionine, which blocks MPO-mediated inactivation of
1PI (6) via its ability to spare methionine
358 within the active site of
1PI (6, 29, 40,
48), did not protect
1PI from the effects of
NADH-pyocyanin (data not shown). In addition, since
O2·
is not generated as a
consequence of pyocyanin reduction under anaerobic conditions, we
assessed the ability of O2 depletion on the process by
bubbling the experimental system with N2 prior to the
addition of pyocyanin. NADH-pyocyanin retained its ability to
inactivate
1PI under O2-depleted conditions
(Fig. 6). That bubbling of N2
effectively depleted the system of O2 was confirmed with
the anaerobic indicator resazurin (33).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 6.
Immunoblot with antisera to 1PI in which
gel samples were comprised of 10 µg of 1PI alone (lane
1) or 10 µg of 1PI alone plus 200 µg of trypsin
(lane 2), which had been incubated for 30 min at 37°C. Lanes 3 and 4 show results obtained under the same conditions as lane 2, except that
6 mM NADH and 100 µM pyocyanin were added prior to the addition of
trypsin to the reaction mixture. The incubation in lane 3 was performed
under standard aerobic conditions, whereas lane 4 reflects results
obtained under O2-depleted conditions in which the reaction
mixture was bubbled with N2 for 20 min prior to the
addition of pyocyanin. The results are representative of three
separate experiments.
|
|
These data do not suggest a role for
O2·
, or subsequently generated
oxidants such as H2O2, in the ability of
reduced pyocyanin to inactivate
1PI. Instead, they raise
the possibility that pyocyanin radical, a reducing species formed by
the initial electron transfer from NADH to pyocyanin, could be
inactivating
1PI via a reducing rather than an oxidizing
reaction. In support of this, exposure of
1PI to the
reducing agent
-mercaptoethanol resulted in an inability of the
1PI to subsequently bind trypsin (Fig.
7). This is in contrast to reports in the
literature (7, 31, 46) and or own experience (data not
shown) that, once formed, the
1PI-trypsin complex does
not dissociate upon exposure to
-mercaptoethanol.

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 7.
Immunoblot with antisera to 1PI in which
gel samples were comprised of 10 µg of 1PI alone (lane
1) or 10 µg of 1PI alone plus 200 µg of trypsin
(lane 2), which had been incubated for 30 min at 37°C. The reaction
in lane 3 was performed under the same conditions as those of lane 2, except that the 1PI had been exposed to 14 mM
-mercaptoethanol prior to the addition of the trypsin. Although not
shown in this figure, addition of -mercaptoethanol after the
completion of the incubation of trypsin and 1PI has no
effect on complex formation.
|
|
 |
DISCUSSION |
An elevated ratio of protease to antiprotease activity has been
detected in the P. aeruginosa-infected airways of
cystic fibrosis patients, and this is felt to contribute to the
pathogenesis of cystic fibrosis lung disease (23, 43, 45).
This imbalance is likely due to the presence of markedly elevated
levels of the serine protease HNE as well as a higher than expected
frequency of inactive
1PI (1, 2, 5, 35, 38,
44). Given the known susceptibility of
1PI to
oxidant-mediated inactivation (6, 14, 17, 34, 41, 52), the
ability of the redox-active P. aeruginosa
secretory product pyocyanin to inactivate
1PI was assessed. Such a process could contribute to protease-mediated lung
injury in cystic fibrosis, as well as potentially necrotizing acute
nosocomial P. aeruginosa. Nearly all strains of
P. aeruginosa are capable of producing pyocyanin.
In support of this hypothesis, we found that the reaction of NADH with
concentrations of pyocyanin reported to be present in sputum sol of
P. aeruginosa-infected cystic fibrosis patients (51), in excess of 100 µM, was able to alter
1PI such that it was no longer able to bind to and
inhibit the enzymatic activity of the serine proteases PPE and trypsin
(binding studies only). The concentration of pyocyanin present in the
lung in the setting of P. aeruginosa pneumonia in the
non-cystic fibrosis-hospitalized patient is not known. Our studies were
performed with concentrations of
1PI and serine
proteases very close to the mean values of 12 and 88 µg of
1PI and human neutrophil elastase, respectively, per ml
reported to be present in the sputum of P. aeruginosa-infected cystic fibrosis patients (38).
Although we would expect a similar effect of pyocyanin exposure on
1PI binding to HNE, this was not assessed due to the
cost-prohibitive requirement of HNE for such studies.
1PI binding to all serine proteases occurs via the same
basic process (32, 40, 48).
Similar to the results with NADH-pyocyanin, in studies in which human
lung epithelial cell monolayers were exposed to pyocyanin,
1PI was inactivated when the protein was present in the
extracellular milieu. Thus, in spite of the intracellular site at which
pyocyanin reduction likely occurs, there was sufficient interaction
between reduced pyocyanin and/or its oxidant products to inactivate
1PI. Previous spin trapping studies with endothelial
cells support the concept that these pyocyanin-derived products do have
access to the extracellular space (4).
Regardless of whether NADH or epithelial cells were employed as the
means of reducing pyocyanin, incubation of pyocyanin-treated
1PI with either trypsin or PPE resulted in the formation
of proteolytic degradation products of
1PI. This
suggests that redox cycling of pyocyanin leads to modifications of
1PI which allow it to be cleaved by the protease rather
than resulting in the formation of an irreversible complex between
1PI and the protease. Oxidant-mediated inactivation of
another airway protease inhibitor, secretory leukocyte protease
inhibitor (SLPI), also renders it more susceptible to proteolysis
(49).
Consistent with our previous work (3, 4, 37) and that of
others (4, 8, 11, 22, 24-26, 42), we found by using EPR
techniques that the addition of NADH to pyocyanin leads to the initial
formation of pyocyanin radical, which in the presence of O2
transfers that electron to O2 to form
O2·
.
O2·
production was also observed
upon the addition of pyocyanin to human airway epithelial cells.
Although not specifically measured, production of
O2·
would lead in turn to the
formation of H2O2 via the dismutation reaction
of O2·
with itself (36).
In view of previous observations that oxidation of methionine 358 at
the
1PI active site is the mechanism whereby MPO-H2O2 inactivates
1PI
(29, 40, 48), we suspected a similar process was involved in
the inactivation of
1PI by pyocyanin. However, several
pieces of data argue against such a mechanism. Free methionine failed
to protect
1PI from the effect of pyocyanin, in contrast
to its reported ability to protect the protein from inactivation by the
MPO-H2O2 system (6). Neither SOD,
catalase, DMTU, nor depletion of O2 from the system altered
the ability of NADH-pyocyanin to inactivate
1PI. These
data argue strongly against a role for pyocyanin-derived
O2·
and/or
H2O2 in the ability of this P. aeruginosa-derived compound to inactivate
1PI.
Thus, pyocyanin-mediated inactivation of
1PI inhibition
does not likely occur via oxidation of methionine at the
1PI active site.
These data raise the possibility that a direct interaction between
1PI and the pyocyanin radical itself, rather than
reactive oxidant species generated from the interaction of reduced
pyocyanin and O2, modifies
1PI such that it
loses its ability to bind serine proteases. Under this hypothesis, the
pyocyanin radical would directly modify
1PI by the
transfer of an electron (reduction) to an amino acid constituent of the
protein resulting in either direct modification of the active site
or alternatively a conformational change in the molecule that
decreases its ability to irreversibly bind serine proteases. This is
consistent with the fact that the pyocyanin radical is predominantly a
reducing radical. Supporting this hypothesis, exposure to the reducing
agent
-mercaptoethanol also resulted in a loss of the ability of
1PI to bind trypsin. We are unaware of studies
investigating the potential for reduction rather than oxidation of
1PI to decrease its ability to bind serine proteases.
What amino acid(s) would be the target of such reduction is difficult
to predict. This hypothesis will need to be further examined with
previously generated site-specific mutations of
1PI as
well as by molecular analysis of the pyocyanin-modified protein.
Although the exact mechanism remains to be definitively defined, our
data are consistent with the potential for pyocyanin present in the
P. aeruginosa-infected airway to cause a local inhibition of
1PI activity, thereby contributing to
protease-mediated tissue injury. It is likely that the pathophysiology
responsible for the protease-antiprotease imbalance which marks the
airway of cystic fibrosis patients is multifactorial. There is an
increased burden of HNE due to the large neutrophilic infiltrate that
marks this disease state. Oxidants produced by the same neutrophils, particularly those derived from MPO-H2O2, also
likely serve to inactivate
1PI. Interestingly, recent
data suggest that pyocyanin, through its ability to induce interleukin
8 release from airway epithelial cells, may contribute to this
neutrophilic infiltration of the airway (13). Besides
1PI, the airway contains other antiproteases, such as
(SLPI), capable of inhibiting HNE (49). SLPI is also
susceptible to oxidant-mediated inactivation (27, 49) due to
the presence of a methionine residue at its active site. Whether SLPI
can also be inactivated by pyocyanin is unknown and is worthy of investigation.
In summary, the present work demonstrates that, once reduced, pyocyanin
can in turn interact with
1PI in such a way that there
is a loss of the protein's ability to form an irreversible complex
with and inhibit the enzymatic activity of serine proteases. Although
the exact mechanism requires further delineation, occurrence of these
events in vivo could contribute to the pathogenesis of serine
protease-mediated injury in P. aeruginosa-infected
lungs of patients with cystic fibrosis chronic lung disease and/or
acute nosocomial P. aeruginosa pneumonia.
 |
ACKNOWLEDGMENTS |
This work was supported in part by research grants from the
Office of Research and Development, Medical Research Service, Department of Veteran Affairs, and the Public Health Service (HL44275 and AI34954), as well as the Cystic Fibrosis Foundation, and was performed during the tenure of B.E.B. as an Established Investigator of
the American Heart Association.
We acknowledge and thank George Rasmussen for performing the spin
trapping studies and Gerene Denning for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, The University of Iowa, 200 Hawkins Dr., SW54 GH, Iowa City, IA 52242. Phone: (319) 356-2883. Fax: (319) 356-4600. E-mail: bradley-britigan{at}mail.int-med.uiowa.edu.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Allen, E. D.
1996.
Opportunities for the use of aerosolized 1-antitrypsin for the treatment of cystic fibrosis.
Chest
110(Suppl.):256S-260S[Medline].
|
| 2.
|
Birrer, P.,
N. G. McElvaney,
A. Rüdeberg,
C. Wirz Sommer,
S. Liechti-Gallati,
R. Kraemer,
R. Hubbard, and R. G. Crystal.
1994.
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Am. J. Respir. Crit. Care Med.
150:207-213[Abstract].
|
| 3.
|
Britigan, B. E.,
G. T. Rasmussen, and C. D. Cox.
1997.
Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin.
Infect. Immun.
65:1071-1076[Abstract].
|
| 4.
|
Britigan, B. E.,
T. L. Roeder,
G. T. Rasmussen,
D. M. Shasby,
M. L. McCormick, and C. D. Cox.
1992.
Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells: implications for pseudomonas-associated tissue injury.
J. Clin. Investig.
90:2187-2196.
|
| 5.
|
Bruce, M. C.,
L. Poncz,
J. D. Klinger,
R. C. Stern,
J. F. Tomashefski, Jr., and D. G. Dearborn.
1985.
Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.
Am. Rev. Respir. Dis.
132:529-535[Medline].
|
| 6.
|
Carp, H., and A. Janoff.
1979.
In vitro suppression of serum-elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.
J. Clin. Investig.
63:793-797.
|
| 7.
|
Christensen, S.,
Z. Valnickova,
I. B. Thogersen,
S. V. Pizzo,
H. R. Nielsen,
P. Roepstorff, and J. J. Enghild.
1995.
Sodium dodecyl sulfate-stable complexes between serpins and active or inactive proteinases contain the region COOH-terminal to the reactive site loop.
J. Biol. Chem.
270:14859-14862[Abstract/Free Full Text].
|
| 8.
|
Cohen, M. S.,
L. M. Charniga,
M. J. Stutts,
J. R. Yankaskas,
D. J. Hassett,
E. Krochmal,
J. T. Gatzy, and R. C. Boucher.
1990.
Effects of Pseudomonas pyocyanin on cystic fibrosis epithelial cells, abstr. 44, p. 94.
In
Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
|
| 9.
|
Cox, C. D.
1986.
Role of pyocyanin in the acquisition of iron from transferrin.
Infect. Immun.
52:263-270[Abstract/Free Full Text].
|
| 10.
|
Crystal, R. G.
1990.
-1-Antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy.
J. Clin. Investig.
85:1342-1352.
|
| 11.
|
Davis, G., and P. J. Thornalley.
1983.
Free radical production from the aerobic oxidation of reduced pyridine nucleotides catalyzed by phenazine derivatives.
Biochim. Biophys. Acta
724:456-464[Medline].
|
| 12.
|
Denning, G. M.,
M. A. Railsback,
G. T. Rasmussen,
C. D. Cox, and B. E. Britigan.
1998.
Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells.
Am. J. Physiol. Lung Cell. Mol. Physiol.
274:L893-L900[Abstract/Free Full Text].
|
| 13.
|
Denning, G. M.,
L. A. Wollenweber,
M. A. Railsback,
C. D. Cox,
L. L. Stoll, and B. E. Britigan.
1998.
Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells.
Infect. Immun.
66:5777-5784[Abstract/Free Full Text].
|
| 14.
|
Desrochers, P. E.,
K. Mookhtiar,
H. E. Van Wart,
K. A. Hasty, and S. J. Weiss.
1992.
Proteolytic inactivation of 1-proteinase inhibitor and 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases.
J. Biol. Chem.
267:5005-5012[Abstract/Free Full Text].
|
| 15.
|
Döring, G.
1994.
The role of neutrophil elastase in chronic inflammation.
Am. J. Respir. Crit. Care Med.
150(Suppl.):S114-S117.
|
| 16.
|
Döring, G.,
W. Goldstein,
A. Röll,
P. O. Schiøtz,
N. Høiby, and K. Botzenhart.
1985.
Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
Infect. Immun.
49:557-562[Abstract/Free Full Text].
|
| 17.
|
Evans, M. D.,
D. F. Church, and W. A. Pryor.
1991.
Aqueous cigarette tar extracts damage human alpha-1-proteinase inhibitor.
Chem. Biol. Interact.
79:151-164[Medline].
|
| 18.
|
Fick, R. B., Jr.
1989.
Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis.
Chest
96:158-164[Free Full Text].
|
| 19.
|
Fick, R. B., Jr., and J. S. Hata.
1989.
Pathogenetic mechanisms in lung disease caused by Pseudomonas aeruginosa.
Chest
95:206S-213S[Free Full Text].
|
| 20.
|
Fick, R. B., Jr.,
G. P. Naegel,
S. U. Squier,
R. E. Wood,
J. B. L. Gee, and H. Y. Reynolds.
1984.
Proteins of the cystic fibrosis respiratory tract: fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
J. Clin. Investig.
74:236-248.
|
| 21.
|
Frank, L. H., and R. D. DeMoss.
1959.
On the biosynthesis of pyocyanine.
J. Bacteriol.
77:776-782[Free Full Text].
|
| 22.
|
Gardner, P. R.
1996.
Superoxide production by the mycobacterial and pseudomonad quinoid pigments phthiocol and pyocyanine in human lung cells.
Arch. Biochem. Biophys.
333:267-274[Medline].
|
| 23.
|
Goldstein, W., and G. Doring.
1986.
Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Am. Rev. Respir. Dis.
134:49-56[Medline].
|
| 24.
|
Hassan, H. M., and I. Fridovich.
1979.
Intracellular production of superoxide radical and hydrogen peroxide by redox active compounds.
Arch. Biochem. Biophys.
196:385-395[Medline].
|
| 25.
|
Hassan, H. M., and I. Fridovich.
1980.
Mechanism of the antibiotic action of pyocyanine.
J. Bacteriol.
141:156-163[Abstract/Free Full Text].
|
| 26.
|
Hassett, D. J.,
L. Charniga,
K. Bean,
D. E. Ohman, and M. S. Cohen.
1992.
Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase.
Infect. Immun.
60:328-336[Abstract/Free Full Text].
|
| 27.
|
Heinzel-Wieland, R.,
G. J. Steffens, and L. Flohé.
1990.
Inhibitory characteristics and oxidation resistance of site-specific variants of recombinant human antileukoproteinase.
Biomed. Biochim. Acta
50:677-681.
|
| 28.
|
Hubbard, R. C.,
F. Ogushi,
G. A. Fells,
A. M. Cantin,
S. Jallat,
M. Courtney, and R. G. Crystal.
1987.
Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
J. Clin. Investig.
80:1289-1295.
|
| 29.
|
Huber, R., and R. W. Carrell.
1989.
Implications of the three-dimensional structure of 1-antitrypsin for structure and function of serpins.
Biochemistry
28:8951-8966[Medline].
|
| 30.
|
Janoff, A.,
H. Carp,
P. Laurent, and L. Raju.
1983.
The role of oxidative processes in emphysema.
Am. Rev. Respir. Dis.
127:S31-S38[Medline].
|
| 31.
|
Johnson, D., and J. Travis.
1979.
The oxidative inactivation of human -1-proteinase inhibitor: further evidence for methionine at the reactive center.
J. Biol. Chem.
254:4022-4026[Free Full Text].
|
| 32.
|
Kraut, J.
1977.
Serine proteases: structure and mechanism of catalysis.
Annu. Rev. Biochem.
46:331-358[Medline].
|
| 33.
|
Mandell, G. L.
1974.
Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils.
Infect. Immun.
9:337-341[Abstract/Free Full Text].
|
| 34.
|
Matheson, N. R.,
P. S. Wong, and J. Travis.
1979.
Enzymatic inactivation of human -1-proteinase inhibitor by neutrophil myeloperoxidase.
Biochem. Biophys. Res. Commun.
88:402-409[Medline].
|
| 35.
|
Meyer, K. C.,
J. R. Lewandoski,
J. J. Zimmerman,
D. Nunley,
W. J. Calhoun, and G. A. Dopico.
1991.
Human neutrophil elastase and elastase/alpha1-antiprotease complex in cystic fibrosis: comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Am. Rev. Respir. Dis.
144:580-585[Medline].
|
| 36.
|
Miller, R. A., and B. E. Britigan.
1995.
The formation and biologic significance of phagocyte-derived oxidants.
J. Investig. Med.
43:39-49[Medline].
|
| 37.
|
Miller, R. A.,
G. T. Rasmussen,
C. D. Cox, and B. E. Britigan.
1996.
Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation.
Infect. Immun.
64:182-188[Abstract].
|
| 38.
|
O'Connor, C. M.,
K. Gaffney,
J. Keane,
A. Southey,
N. Byrne,
S. O'Mahoney, and M. X. Fitzgerald.
1993.
1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis.
Am. Rev. Respir. Dis.
148:1665-1670[Medline].
|
| 39.
|
Ossanna, P. J.,
S. T. Test,
N. R. Matheson,
S. Regiani, and S. J. Weiss.
1986.
Oxidative regulation of neutrophil elastase-alpha-a-proteinase inhibitor interactions.
J. Clin. Investig.
77:1939-1951.
|
| 40.
|
Potempa, J.,
E. Korzus, and J. Travis.
1994.
The serpin superfamily of proteinase inhibitors: structure, function, and regulation.
J. Biol. Chem.
269:15957-15960[Free Full Text].
|
| 41.
|
Pryor, W. A.,
M. M. Dooley, and D. F. Church.
1986.
The inactivation of -1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species.
Chem. Biol. Interact.
57:271-283[Medline].
|
| 42.
|
Schellhorn, H. E.,
S. Pou,
C. Moody, and H. M. Hassan.
1989.
An electron spin resonance study of oxyradical generation in superoxide dismutase- and catalase-deficient mutants of Escherichia coli K-12.
Arch. Biochem. Biophys.
271:323-331[Medline].
|
| 43.
|
Suter, S.
1989.
The imbalance between granulocyte neutral proteases and antiproteases in bronchial secretions from patients with cystic fibrosis.
Antibiot. Chemother.
42:158-168[Medline].
|
| 44.
|
Suter, S.
1994.
The role of bacterial proteases in the pathogenesis of cystic fibrosis.
Am. J. Respir. Crit. Care Med.
150(Suppl.):S118-S122.
|
| 45.
|
Suter, S.,
O. B. Schaad,
L. Roux,
U. E. Nydegger, and F. A. Waldvogel.
1984.
Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis.
J. Infect. Dis.
149:523-531[Medline].
|
| 46.
|
Thomas, R. M.,
W. M. Nauseef,
S. S. Iyer,
M. W. Peterson,
P. J. Stone, and R. A. Clark.
1991.
A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
J. Leukocyte Biol.
50:568-579[Abstract].
|
| 47.
|
Travis, J., and D. Johnson.
1981.
Human 1-proteinase inhibitor.
Methods Enzymol.
80:754-765.
|
| 48.
|
Travis, J., and G. S. Salvesen.
1983.
Human plasma proteinase inhibitors.
Annu. Rev. Biochem.
52:655-709[Medline].
|
| 49.
|
Vogelmeier, C.,
R. C. Hubbard,
G. A. Fells,
H.-P. Schnebli,
R. C. Thompson,
H. Fritz, and R. G. Crystal.
1991.
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
J. Clin. Investig.
87:482-488.
|
| 50.
|
Weiss, S. J., and S. Regiani.
1984.
Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.
J. Clin. Investig.
73:1297-1303.
|
| 51.
|
Wilson, R.,
D. A. Sykes,
D. Watson,
A. Rutman,
G. W. Taylor, and P. J. Cole.
1988.
Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium.
Infect. Immun.
56:2515-2517[Abstract/Free Full Text].
|
| 52.
|
Zaslow, M. C.,
R. A. Clark,
P. J. Stone,
J. D. Calore,
G. L. Snider, and C. Franzblau.
1983.
Human neutrophil elastase does not bind alpha1-protease inhibitor that has been exposed to activated human neutrophils.
Am. Rev. Respir. Dis.
128:434-439[Medline].
|
Infection and Immunity, March 1999, p. 1207-1212, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
MacEachran, D. P., Stanton, B. A., O'Toole, G. A.
(2008). Cif Is Negatively Regulated by the TetR Family Repressor CifR. Infect. Immun.
76: 3197-3206
[Abstract]
[Full Text]
-
Abusriwil, H., Stockley, R. A.
(2007). The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage. Proc Am Thorac Soc
4: 611-617
[Abstract]
[Full Text]
-
MacEachran, D. P., Ye, S., Bomberger, J. M., Hogan, D. A., Swiatecka-Urban, A., Stanton, B. A., O'Toole, G. A.
(2007). The Pseudomonas aeruginosa Secreted Protein PA2934 Decreases Apical Membrane Expression of the Cystic Fibrosis Transmembrane Conductance Regulator. Infect. Immun.
75: 3902-3912
[Abstract]
[Full Text]
-
Lau, G. W., Ran, H., Kong, F., Hassett, D. J., Mavrodi, D.
(2004). Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice. Infect. Immun.
72: 4275-4278
[Abstract]
[Full Text]
-
Ran, H., Hassett, D. J., Lau, G. W.
(2003). Human targets of Pseudomonas aeruginosa pyocyanin. Proc. Natl. Acad. Sci. USA
100: 14315-14320
[Abstract]
[Full Text]
-
O'Malley, Y. Q., Reszka, K. J., Rasmussen, G. T., Abdalla, M. Y., Denning, G. M., Britigan, B. E.
(2003). The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
285: L1077-L1086
[Abstract]
[Full Text]
-
Gallagher, L. A., Manoil, C.
(2001). Pseudomonas aeruginosa PAO1 Kills Caenorhabditis elegans by Cyanide Poisoning. J. Bacteriol.
183: 6207-6214
[Abstract]
[Full Text]
-
Van der Vliet, A., Nguyen, M. N., Shigenaga, M. K., Eiserich, J. P., Marelich, G. P., Cross, C. E.
(2000). Myeloperoxidase and protein oxidation in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol.
279: L537-L546
[Abstract]
[Full Text]